Correlation Between Align Technology and Talis Biomedical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Align Technology and Talis Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Align Technology and Talis Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Align Technology and Talis Biomedical Corp, you can compare the effects of market volatilities on Align Technology and Talis Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Align Technology with a short position of Talis Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Align Technology and Talis Biomedical.

Diversification Opportunities for Align Technology and Talis Biomedical

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Align and Talis is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Align Technology and Talis Biomedical Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Talis Biomedical Corp and Align Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Align Technology are associated (or correlated) with Talis Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Talis Biomedical Corp has no effect on the direction of Align Technology i.e., Align Technology and Talis Biomedical go up and down completely randomly.

Pair Corralation between Align Technology and Talis Biomedical

Given the investment horizon of 90 days Align Technology is expected to under-perform the Talis Biomedical. But the stock apears to be less risky and, when comparing its historical volatility, Align Technology is 1.07 times less risky than Talis Biomedical. The stock trades about -0.35 of its potential returns per unit of risk. The Talis Biomedical Corp is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  907.00  in Talis Biomedical Corp on February 28, 2024 and sell it today you would lose (7.00) from holding Talis Biomedical Corp or give up 0.77% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Align Technology  vs.  Talis Biomedical Corp

 Performance 
       Timeline  
Align Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Align Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in June 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Talis Biomedical Corp 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Talis Biomedical Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady forward indicators, Talis Biomedical may actually be approaching a critical reversion point that can send shares even higher in June 2024.

Align Technology and Talis Biomedical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Align Technology and Talis Biomedical

The main advantage of trading using opposite Align Technology and Talis Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Align Technology position performs unexpectedly, Talis Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Talis Biomedical will offset losses from the drop in Talis Biomedical's long position.
The idea behind Align Technology and Talis Biomedical Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
CEOs Directory
Screen CEOs from public companies around the world